Cleared Traditional

K242759 - Geister K-Rex rongeurs

K242759 is an FDA 510(k) clearance for Geister K-Rex rongeurs, manufactured by Geister Medizin Technik GmbH. The device is a Class 2 Neurology device with product code HAE cleared through the Traditional 510(k) pathway after a 267-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jun 2025
Decision
267d
Days
Class 2
Risk

K242759 is an FDA 510(k) clearance for the Geister K-Rex rongeurs. Classified as Rongeur, Manual (product code HAE), Class II - Special Controls.

Submitted by Geister Medizin Technik GmbH (Tuttlingen, DE). The FDA issued a Cleared decision on June 6, 2025 after a review of 267 days - an extended review cycle.

This device falls under the Neurology FDA review panel, regulated under 21 CFR 882.4840 - the FDA neurology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Neurology review framework, consistent with the majority of Class II 510(k) submissions.

View all Geister Medizin Technik GmbH devices

FDA 510(k) Submission Details - K242759

510(k) Number K242759 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received September 12, 2024
Decision Date June 06, 2025
Days to Decision 267 days
Submission Type Traditional
Review Panel Neurology (NE)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
119d slower than avg
Panel avg: 148d · This submission: 267d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

HAE Device Classification - Class 2, Special Controls

Product Code HAE Rongeur, Manual
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 882.4840
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Neurology devices follow this clearance model.

Regulatory Peers - HAE Rongeur, Manual

All 13
Devices cleared under the same product code (HAE) and FDA review panel - the closest regulatory comparables to K242759.
SQ.line KERRISON
K223596 · Aesculap, Inc. · Jun 2023
Rebellion, Phantom Multi-Bite Kerrison Rongeur
K230256 · Morpheus AG · Mar 2023
Rebellion
K221818 · Morpheus AG · Oct 2022
KLS Martin Neuro Rongeurs
K210741 · KLS-Martin L.P. · Jun 2022
Rebellion, Phantom Multi-Bite Kerrison Rongeur 
K200768 · Morpheus AG · May 2021
Wiggins Medical Surgical Instruments
K200383 · Wiggins Medical · Jul 2020